Niacin (vitamin B3)
Also called: vitamin B3, nicotinic acid, nicotinamide, niacinamide, inositol hexanicotinate
A water-soluble B vitamin; niacin is the generic name for nicotinic acid, nicotinamide and related compounds, converted in the body to NAD, which more than 400 enzymes require. The body also makes NAD from tryptophan. Sources include poultry, beef, fish, nuts, legumes and enriched grains.
- Category
- Vitamin
- Forms
- Nicotinic acid, nicotinamide; inositol hexanicotinate
- Strongest evidence
- A Strong
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2017 Cochrane review pooled 23 RCTs (39,195 participants) of niacin taken for at least 6 months, either alone versus placebo or usual care, or added to other therapy (often a statin) versus that therapy alone. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
AHeart and blood vessels2 topics
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Cardiovascular events and mortality (nicotinic acid) | X | A 2017 Cochrane review (23 RCTs, 39,195 participants; median 2 g/day) found no reduction in overall or cardiovascular mortality. HPS2-THRIVE (25,673 adults on statins) and AIM-HIGH (3,414 patients) found no fewer cardiovascular events. [1] |
| Blood lipid profile (nicotinic acid) | A | ODS summarizes the trials as showing that nicotinic acid improves blood lipid profiles but has no significant effects on risk of cardiovascular events. [1] |
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- RDA, adults 19+: men 16 mg NE; women 14 mg NE; pregnancy 18 mg NE; lactation 17 mg NE (1 mg NE = 1 mg niacin or 60 mg tryptophan). [1]
- Cardiovascular trials used pharmacologic doses: 3,000 mg/day nicotinic acid (Coronary Drug Project, 6.2 years), 2 g/day extended-release (HPS2-THRIVE, median 4 years), 1,500–2,000 mg/day extended-release (AIM-HIGH). [1]
- For pellagra, WHO recommends 300 mg/day nicotinamide in divided doses for 3–4 weeks, with a B-complex or yeast product. [1]
Upper limits
- UL, adults 19+ (including pregnancy and lactation): 35 mg. The UL applies only to supplemental niacin, not to individuals receiving supplemental niacin under medical supervision. [1]
Safety and side effects
- Liver (NIH LiverTox)Score AABCDEA: well known causeE: unlikely cause
LiverTox likelihood score A[HD]: well known cause of clinically apparent liver injury when given in high doses (chapter last updated July 9, 2020).
Details and sources - Pregnancy and breastfeedingRDA in pregnancy: 18 mg NE/day; in lactation: 17 mg NE/day. UL in pregnancy and lactation: 30 mg/day (ages 14–18) and 35 mg/day (19 and older) …
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Isoniazid and pyrazinamide; Antidiabetes medications
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications12 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Thirty to 50 mg or more nicotinic acid typically causes flushing, with burning, tingling and itching. [1]
- Pharmacologic doses (1,000–3,000 mg/day nicotinic acid) can cause hypotension, glucose intolerance, gastrointestinal effects and macular edema; doses of 1.5 g/day or more are most likely to raise blood glucose. [1]
- High doses of nicotinic acid taken over months or years can be hepatotoxic; extended-release forms carry higher risk. [1]
- HPS2-THRIVE found a significantly greater risk of diabetes with nicotinic acid; AIM-HIGH found an increased risk of ischemic stroke. [1]
- Nausea, vomiting and signs of liver toxicity can occur with nicotinamide intakes of 3,000 mg/day. [1]
- Groups at risk of inadequacy: people with undernutrition (including alcohol use disorder, AIDS, inflammatory bowel disease, liver cirrhosis), low riboflavin, B6 or iron intake, Hartnup disease or carcinoid syndrome. Severe deficiency causes pellagra. [1]
Interactions
| With | What happens |
|---|---|
| Isoniazid and pyrazinamide | These tuberculosis drugs are structural analogs of niacin and interrupt niacin production from tryptophan; pellagra can be averted with more niacin. [1] |
| Antidiabetes medications | High-dose nicotinic acid can raise blood glucose; blood glucose should be monitored and dose adjustments may be needed. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: available in dietary supplements; prescription extended-release niacin provides 500–1,000 mg nicotinic acid for high cholesterol. The FDA Daily Value is 16 mg for adults and children age 4 years and older. [1]
- FDA stated in October 2022 that NMN was excluded from the definition of a dietary supplement, but on September 29, 2025, responding to a citizen petition (docket FDA-2023-P-0872), it concluded that NMN is not excluded. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Nicotinic acid and nicotinamide (the most common supplement forms); inositol hexanicotinate Niacin forms (vitamin) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 12 entries naming niacin, niacinamide or nicotinic acid (earliest NDI 491 submitted 2007-12-03; most recent NDI 910 submitted 2016-02-01); most are multi-ingredient combinations. Entries for nicotinamide riboside and nicotinamide mononucleotide are counted separately. Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score A[HD]: well known cause of clinically apparent liver injury when given in high doses (chapter last updated July 9, 2020). [P2]
- Transient, asymptomatic serum aminotransferase elevations occur in up to 20% of people taking more than 500 mg daily; significant hepatotoxicity is particularly common with high doses of sustained-release niacin. [P2]
Interactions with medicines
- Isoniazid and pyrazinamide: These tuberculosis drugs are structural analogs of niacin and interrupt niacin production from tryptophan; isoniazid can also interfere with niacin's conversion to NAD. Pellagra can occur in patients treated with isoniazid. [P1]
- Antidiabetes medications: Large doses of nicotinic acid can raise blood glucose (doses of 1.5 g/day or more are most likely to); people taking antidiabetes medications with high-dose nicotinic acid should have blood glucose monitored and might need dose adjustments. [P1]
Alcohol
- People who are undernourished because of alcohol use disorder often have inadequate niacin intakes. [P1]
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient, before use — Required by 21 CFR 111.75(a)(1)(i); a manufacturer may petition for an exemption from this testing under 111.75(a)(1)(ii). [P6]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Even in very high doses of 3–4 g, niacin is almost completely absorbed, primarily in the small intestine. [P1]
- Absorption of niacin from inositol hexanicotinate varies widely and is on average 30% lower than from nicotinic acid or nicotinamide; niacin naturally present in grains is largely bound to polysaccharides and glycopeptides. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- RDA in pregnancy: 18 mg NE/day; in lactation: 17 mg NE/day. UL in pregnancy and lactation: 30 mg/day (ages 14–18) and 35 mg/day (19 and older); the UL applies to supplemental niacin. [P1]
Sources for this profile
- NIH Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals (updated November 18, 2022), 2022-11-18. ods.od.nih.gov
- NIH LiverTox (NIDDK). Niacin (Last Update: July 9, 2020), 2020-07-09. ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (accessed October 29, 2026), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR) list (accessed October 29, 2026), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75 (title 21 displayed up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals (updated November 18, 2022), 2022-11-18. ods.od.nih.gov
- Schandelmaier S, et al. Niacin for primary and secondary prevention of cardiovascular events. Cochrane Database Syst Rev 2017;(6):CD009744 (PMID 28616955), 2017-06-14. pubmed.ncbi.nlm.nih.gov
- U.S. FDA, Human Foods Program (D. Prater). Letter responding to the NPA and ANH-USA citizen petition on beta-nicotinamide mononucleotide (NMN), docket FDA-2023-P-0872 (posted to the docket September 29, 2025), 2025-09-29. downloads.regulations.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · Thiamin (vitamin B1) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.